More about

Antipsychotic Agent

News
December 23, 2021
2 min read
Save

Antipsychotics linked to decreased assault risk for emergency personnel

Use of antipsychotic medication in psychiatric patients led to decreases in assault risk against personnel within emergency settings, according to a longitudinal study published in the Journal of Clinical Psychiatry.

News
December 13, 2021
2 min read
Save

Combination products containing opioid antagonists: What prescribers need to know

FDA recently approved Lybalvi for the treatment of schizophrenia and for use in manic and mixed (depressive and manic) episodes of bipolar I disorder as an acute treatment, a maintenance treatment, and for use with valproate or lithium.

News
November 11, 2021
1 min read
Save

Veterans’ mental health: Combat and suicide attempt, respiratory therapy for PTSD, more

In conjunction with Veterans Day, Healio Psychiatry has compiled a list of recent research related to veteran mental health.

News
November 01, 2021
2 min read
Save

Most LAI antipsychotic prescribers report pandemic has not affected prescribing

Most frequent prescribers of long-acting injectable antipsychotics reported no changes in prescribing during the COVID-19 pandemic, according to results of a health care provider survey study presented at Psych Congress.

News
October 11, 2021
1 min read
Save

Implantable monitor detects arrhythmias in patients on psychotropic medications

An implantable loop recorder feasibly and acceptably monitored arrythmias among patients taking psychotropic medication, according to results of a cohort study in a research letter published in JAMA Psychiatry.

News
October 04, 2021
2 min read
Save

Caplyta reduces bipolar disorder-associated depressive episodes

Caplyta reduced depression symptoms in patients with major depressive episodes linked to bipolar I and bipolar II disorders, according to a phase 3 randomized placebo-controlled trial in American Journal of Psychiatry.

News
September 22, 2021
2 min read
Save

Antipsychotics do not increase COVID-19 mortality risk

Antipsychotic treatment did not increase risk for mortality among adults with serious mental illness diagnosed with COVID-19 infection, according to study results in a research letter published in JAMA Psychiatry.

News
September 07, 2021
1 min read
Save

FDA accepts NDA for subcutaneous risperidone injectable

Teva Pharmaceuticals and MedinCell announced FDA acceptance of a new drug application for risperidone extended-release injectable suspension for subcutaneous use, a schizophrenia treatment.

News
August 31, 2021
2 min read
Save

Low doses of antipsychotics may help prevent schizophrenia relapse

Researchers identified a correlation between low doses of antipsychotics and relapse prevention in schizophrenia, according to findings published in JAMA Psychiatry.

News
August 26, 2021
1 min read
Save

Study offers ‘some reassurance’ about prenatal antipsychotic use

Researchers reported that prenatal use of antipsychotics was not associated with risks for adverse outcomes in children — specifically, ADHD, autism spectrum disorder, preterm birth or being born small for gestational age.

View more